期刊文献+

再次肝移植术后继发喉部神经内分泌癌1例 被引量:5

Suffering from secondary laryngeal neuroendocrine carcinoma after liver retransplantation,one case report
下载PDF
导出
摘要 目的:探讨肝移植术后免疫抑制状态下肿瘤发病率的变化及临床对策。方法:1例患者男性,51岁,先后因肝癌及肿瘤复发行2次肝移植术,术后给予联合免疫抑制治疗,再次肝移植术后出现急性排斥反应,给甲强龙冲击治疗。结果:再次肝移植术后一年继发喉神经内分泌癌,行喉癌根治术+放疗。结论:肝移植术后免疫抑制状态会提高某些肿瘤的发病率,有根治指征时,果断进行根治手术是能惠及病人的最佳策略。 Objective:To discuss the changing of tumor incidence rate under immunosuppress state after liver transplantation and clinical countermeasure. Methods :The patient is male,51 years old, He accepted liver transplantation twice for liver cancer and recurrent of the tumor. Results: He suffered from secondary laryngeal neuroendocrine carcinoma after one year to liver retransplantation. Total laryngectomy and cervical target radiotherapy were performed, Conclusion:After liver transplantation the immunosuppressive state will increase certain tumor incidence. If there are radical indications,radical surgery will be the best strategy.
出处 《现代肿瘤医学》 CAS 2008年第7期1210-1211,共2页 Journal of Modern Oncology
关键词 肝移植 神经内分泌癌 免疫抑制状态 liver transplantation neuroendocrine carcinoma immunosuppressive state
  • 相关文献

参考文献12

  • 1naca N, Davis GL, Goldstein RM,et al. Expanded criteria for liver transplantation in patients with hepatoeellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation[J]. Liver Transpl, 2007,13(3) :391 -399.
  • 2Margarit C, Charco R, Hidalgo E, et al. Liver transplantation for malignant diseases : selection and pattern of recurrence [ J ]. World J Surg,2002,26(2) :257 -263.
  • 3贺轶锋,樊嘉,周俭,吴志全,邱双健,黄晓武,余耀,孙健,肖永胜,杨国欢,宋康,王征,汤钊猷,王玉琦.影响肝癌肝移植预后的高危因素分析及诊治经验[J].中华医学杂志,2006,86(18):1232-1235. 被引量:27
  • 4樊嘉,周俭,徐泱,邱双健,吴志全,余耀,黄晓武,汤钊猷,王玉琦.肝癌肝移植适应证的选择:上海复旦标准[J].中华医学杂志,2006,86(18):1227-1231. 被引量:121
  • 5Dympna M, Kelly, Sukru Emre, et al. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors [ J ]. Cancer, 1998, 83 (6) : 1237 - 1243
  • 6Sven Jonas, Nada Rayes, Ulf Neumann, et al. De novo malignancies after liver transplantation using tacrolimus - based protocols or cyclosporine- based quadruple immunosuppression with an interleukin - 2 receptor antibody or antithymocyte globulin [ J ]. Cancer, 1997,80(6) :1141 - 1150
  • 7Vajdic CM, McDonald SP, McCredie MR, et al. Cancer incidence before and after kidney transplantation [ J ]. JAMA, 2006, 296 (23) :2823 - 2831
  • 8Fabia R,Levy MF, Testa G, et al. Colon carcinoma in patients undergoing liver transplantation [ J ]. Am J Surg, 1998,176 ( 3 ) : 265 - 269.
  • 9Ampil FL, Ghali GE,Munker R, et al. De novo head and neck carcinoma in transplant recipients: preliminary results of management[J]. J Oral Maxillofac Surg, 2006,64(7) :1081 -1085.
  • 10潘晓鸣,王勇,薛武军,田普训,丁小明,燕航,候军,冯新顺,项和立.肾移植患者最适免疫抑制状态的初步探讨[J].中国免疫学杂志,2007,23(1):44-45. 被引量:1

二级参考文献29

  • 1李磊,张同琳,宋世兵,修典荣,袁炯,朱建平,蒋斌,王昌明.存在门静脉血栓及癌栓的肝癌患者的肝移植[J].中华器官移植杂志,2005,26(3):136-138. 被引量:4
  • 2黄成,樊嘉,周俭,刘银坤,崔杰峰,康晓楠,杨芃原,汤钊猷.肝细胞癌门静脉癌栓形成相关的血清蛋白质分子标记物研究[J].中华医学杂志,2005,85(11):781-785. 被引量:24
  • 3Parkin DM,Bray F,Ferlay J,et al.Global cancer statistics,2002.CA Cancer J Clin,2005,55:74-108.
  • 4Tang ZY,Ye SL,Liu YK,et al.A decade's studies on metastasis of hepatocellular carcinoma.J Cancer Res Clin Oncol,2004,130:187-196.
  • 5Mazzaferro V,Regalia E,Doci R,et al.Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.N Engl J Med,1996,334:693-699.
  • 6Leung JY,Zhu AX,Gordon FD,et al.Liver transplantation outcomes for early-stage hepatocellular carcinoma:results of a multicenter study.Liver Transpl,2004,10:1343-1354.
  • 7Khakhar A,Solano E,Stell D,et al.Survival after liver transplantation for hepatocellular carcinoma.Transplant Proc,2003,35:2438-2441.
  • 8Fernandez JA,Robles R,Marin C,et al.Can we expand the indications for liver transplantation among hepatocellular carcinoma patients with increased tumor size? Transplant Proc,2003,35:1818-1820.
  • 9Lee KW,Park JW,Joh JW,et al.Can we expand the milan criteria for hepatocellular carcinoma in living donor liver transplantation? Transplant Proc,2004,36:2289-2290.
  • 10Marsh JW,Dvorchik I,Bonham CA,et al.Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer,2000,88:538-543.

共引文献137

同被引文献53

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部